SynthesisClinical and experimental medicine2022

Differences in lymphoma patients between chimeric antigen receptor T-cell therapy trials and the general population.

Eric A Apaydin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.